Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DNTH
DNTH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DNTH News
Leads Biolabs Partners with Dianthus to Advance LBL-047 Clinical Development
4d ago
Globenewswire
Leads Biolabs Partners with Dianthus to Advance LBL-047 Clinical Development
4d ago
Newsfilter
Dianthus Therapeutics Q1 Earnings Beat Expectations
5d ago
seekingalpha
Dianthus Grants Equity Awards to New Employees
May 01 2026
Newsfilter
Dianthus Therapeutics CFO Sells Shares for Profit
Apr 19 2026
Fool
Dianthus Therapeutics CFO Sells Shares in Major Transaction
Apr 19 2026
NASDAQ.COM
Dianthus Executive Sells 114,367 Shares for $9.49 Million
Apr 06 2026
Fool
Savitz Sells 114,367 Shares of Dianthus for $9.49 Million
Apr 06 2026
NASDAQ.COM
Dianthus Therapeutics Shares Surge 5.6% on Positive Pipeline News
Apr 01 2026
NASDAQ.COM
Dianthus Therapeutics FDA Approves Clinical Changes for Claseprubart
Mar 26 2026
seekingalpha
5AM Venture Management Fully Exits Dianthus Therapeutics
Mar 18 2026
Fool
Dianthus Therapeutics Hits Early 'Go' in CAPTIVATE Phase 3 CIDP Trial
Mar 15 2026
Yahoo Finance
Dianthus Therapeutics (DNTH.US) Director Plans to Sell $10.55 Million in Common Stock via Form 144
Mar 12 2026
moomoo
Dianthus Therapeutics Prices $625 Million Upsized Public Offering
Mar 11 2026
NASDAQ.COM
Dianthus Therapeutics Prices Upsized $625 Million Public Offering
Mar 11 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 10 2026
Benzinga
Show More News
